Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy

Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy

Stephanie Chen,1 Marc Miravitlles,2 Chin Kook Rhee,3 Ian D Pavord,4 Rupert Jones,5 Victoria Carter,6 Benjamin Emmanuel,1 Marianna Alacqua,7 David B Price6,8 1BioPharmaceuticals Medical, Respiratory & Immunology, AstraZeneca, Gaithersburg, MD, USA; 2Pneumology Department, Hospital Universitari Va...

Full description

Bibliographic Details
Main Authors:	Chen S, Miravitlles M, Rhee CK, Pavord ID, Jones R, Carter V, Emmanuel B, Alacqua M, Price DB
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-09-01
Series:	International Journal of COPD
Subjects:	chronic obstructive pulmonary disease disease burden eosinophils exacerbations health care resource utilization
Online Access:	https://www.dovepress.com/patients-with-chronic-obstructive-pulmonary-disease-and-evidence-of-eo-peer-reviewed-fulltext-article-COPD

Similar Items

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
by: Vestbo J, et al.
Published: (2019-04-01)

Relationship Between Blood Eosinophils and Systemic Corticosteroid Therapy in COPD Exacerbation
by: Gong Y, et al.
Published: (2022-09-01)

COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
by: Osman Savran, et al.
Published: (2021-02-01)

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
by: Claus F. Vogelmeier, et al.
Published: (2019-08-01)

Association of eosinophil‐derived neurotoxin levels with asthma control status in patients with aspirin‐exacerbated respiratory disease
by: Ga‐Young Ban, et al.
Published: (2023-03-01)

Stability of Blood Eosinophils in COPD with Multiple Acute Exacerbations Within 1 Year and Its Relationship with Prognosis
by: Gong Y, et al.
Published: (2022-12-01)

Prediction value of neutrophil and eosinophil count at risk of COPD exacerbation
by: Tzu-Tao Chen, et al.
Published: (2023-12-01)

Exacerbation and Cardiovascular Events in Eosinophilic Chronic Obstructive Pulmonary Disease
by: Mami Orimo, et al.
Published: (2023-04-01)

The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
by: Choi J, et al.
Published: (2019-05-01)

Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease
by: Kwok WC, et al.
Published: (2023-06-01)

Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis
by: Wang Chun Kwok, et al.
Published: (2023-06-01)

Blood eosinophil variability in patients presenting with acute exacerbations of COPD within the past year and its correlation with treatment plan
by: Samir Mohamed Mahmoud Fahyim, et al.
Published: (2024-03-01)

Differences in the lipid metabolism profile and clinical characteristics between eosinophilic and non-eosinophilic acute exacerbation of chronic obstructive pulmonary disease
by: Yating Wang, et al.
Published: (2023-07-01)

Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts
by: Müllerová H, et al.
Published: (2019-03-01)

Blood eosinophils and C-reactive protein as prognostic factors in severe chronic obstructive pulmonary disease exacerbations
by: Hamed A. Hafiz, et al.
Published: (2020-01-01)

Blood and sputum eosinophilia in COPD exacerbation
by: Laila Ashour Helala, et al.
Published: (2022-09-01)

Association Between Blood Eosinophils and Mortality in Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study
by: Yang J, et al.
Published: (2021-02-01)

Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy
by: Benson VS, et al.
Published: (2019-11-01)

Predictors of Influenza PCR Positivity in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
by: Chen CYJ, et al.
Published: (2022-01-01)

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials
by: Dave Singh, et al.
Published: (2020-09-01)

Heterogeneity of asthma–COPD overlap syndrome
by: Joo H, et al.
Published: (2017-02-01)

Correlation between FEV1% Predicted and Blood Eosinophils in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
by: Alfian Nurfaizi, et al.
Published: (2021-05-01)

Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease
by: Hiroki Tashiro, et al.
Published: (2020-12-01)

Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients
by: Laura Millares, et al.
Published: (2019-06-01)

Low Eosinophil Phenotype Predicts Noninvasive Mechanical Ventilation Use in Patients with Hospitalized Exacerbations of COPD [Corrigendum]
by: Wei T, et al.
Published: (2022-03-01)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
by: Russell REK, et al.
Published: (2019-05-01)

Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes
by: Aksoy E, et al.
Published: (2018-09-01)

A systematic review and integrated analysis of biologics that target Type 2 inflammation to treat COPD with increased peripheral blood eosinophils
by: Hiroshi Ohnishi, et al.
Published: (2022-06-01)

Can eosinophilia and neutrophil–lymphocyte ratio predict hospitalization in asthma exacerbation?
by: Hossein Esmaeilzadeh, et al.
Published: (2021-02-01)

Relationship between Peripheral Blood Eosinophil Count and Neutrophil/Lymphocyte Ratio with Number of Attacks Leading to Hospital Admission in Chronic Obstructive Pulmonary Disease
by: Maryam Mirzaee, et al.
Published: (2020-12-01)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
by: Steven W. Yancey, et al.
Published: (2019-09-01)

Persistent Eosinophilic Inflammation in Adult Asthmatics with High Serum and Urine Levels of Leukotriene E4
by: Ban GY, et al.
Published: (2021-10-01)

Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease
by: Mkorombindo T, et al.
Published: (2019-08-01)

Sputum cell counts to manage prednisone-dependent asthma: effects on FEV1 and eosinophilic exacerbations
by: Afia Aziz-Ur-Rehman, et al.
Published: (2017-04-01)

Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
by: Haldar P
Published: (2017-06-01)

Blood Eosinophils and Clinical Outcomes in Inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study
by: Pu J, et al.
Published: (2023-02-01)

Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD
by: Zysman M, et al.
Published: (2017-06-01)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
by: Siddiqui SH, et al.
Published: (2018-11-01)

Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey
by: Miravitlles M, et al.
Published: (2022-07-01)

Computed tomography findings of paranasal sinuses in patients with eosinophilic granulomatosis with polyangiitis: Comparison with other eosinophilic sinus diseases and clinical relevance of their severity
by: Maki Iwata, et al.
Published: (2023-07-01)